overview

Holigos® IBS Restore Clinical Trial

Holigos® IBS Restore is a medical food for the dietary management of IBS. It has been shown in a clinical study of 317 participants to beneficially alter the gut microbiome. The objective of this trial was to determine whether administering once-daily Holigos® IBS Restore would relieve the symptoms of IBS.

holigos-coral-wave holigos-coral-wave-desktop

Key Facts

The trial demonstrated that Holigos® IBS Restore benefited all IBS subtypes across multiple endpoints:

A unique offering

Trial Details

Holigos® IBS Restore was studied in a 12-week, multi-center, open-label trial in patients with IBS.

1

Patients completing the trial took Holigos® IBS Restore (5g) once daily for 12 weeks

2

Holigos® IBS Restore is a neutral powder that is provided in a carton box of 28 single-dose packets

Results

Three hundred seventeen (317) IBS patients were supplied with Holigos® IBS Restore (intention-to-treat, ITT) and 273 patients completed the study.

Overall IBS Severity Score

overall-ibs-severity-score-data

Change in Bristol stool

changes-in-stool-data
holigos-coral-wave holigos-coral-wave-desktop

Summary

Holigos® IBS Restore is safe and well-tolerated.

1

The ingredients in Holigos® are well tolerated by those suffering from IBS

2

Common side effects associated with Holigos® IBS Restore included mild local symptoms in the gut, such as abdominal pain, distension, and flatulence

Want More Details?

Speak with your healthcare provider today about dietary management of IBS.

A clinical trial presented by the American College of Gastroenterology

Download White Paper